Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Resistance to 3rd Generation Thyrosine Kinase Inhibitors in Lung Cancer

NCT04546282 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04546282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04546282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Resistance to 3rd Generation Thyrosine Kinase Inhibitors in Lung Cancer
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
July 1, 2017
Completion date
November 28, 2020
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer